Annual Congress of the European Association of Nuclear Medicine October 12 – 16, 2019 Barcelona, Spain.

Is to design personalised, super-selective therapies and to identify more precise means of monitoring response to treatment in routine The now well-established tracks M2M - Molecule to Man (basic and translational science) and Do.MoRe (radionuclide therapy and dosimetry) promise to promote high-qual...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Nuclear Medicine & Molecular Imaging Vol. 46; pp. 1 - 953
Formato: Journal Article
Publicado: Springer Nature Oct2019 Supplement 1
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139095731&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139095731
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        16197070
        NPC
      jtl: European Journal of Nuclear Medicine & Molecular Imaging
      issn: 16197070
      maglogo: N
    pubinfo:
      dt: Oct2019 Supplement 1
      vid: 46
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        139095731
        10.1007/s00259-019-04486-2
        139095731
      ppf: 1
      ppct: 952
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Annual Congress of the European Association of Nuclear Medicine October 12 – 16, 2019 Barcelona, Spain.
      aug:
      sug:
      ab: Is to design personalised, super-selective therapies and to identify more precise means of monitoring response to treatment in routine The now well-established tracks M2M - Molecule to Man (basic and translational science) and Do.MoRe (radionuclide therapy and dosimetry) promise to promote high-quality research through interaction between basic and translational clinical Scientists and to present the latest achievements and developments in the fields of clinical molecular imaging and nuclear medicine therapy. Radiobiology and Dosimetry for Radioembolisation Therapy Problems Related to Dosimetry for Therapy Based on.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Unknown
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N